Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 8/20 | 0.44 |
| ▸ | CA1 | P00915 | 7/20 | 0.44 |
| ▸ | CA12 | O43570 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 6/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.44 |
| ▸ | TLR4 | O00206 | 2/20 | 0.43 |
| ▸ | ANTXR2 | P58335 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 2/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13621251 | 1.00 | MAPT (0.49) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL3334421 | 1.00 | MAPT (0.49) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL20582014 | 1.00 | MAPT (0.49) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL16500298 | 1.00 | MAPT (0.49) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL3336043 | 1.00 | MAPT (0.49) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL19079629 | 0.98 | MAPT (0.47) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL22107783 | 0.96 | MAPT (0.46) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL22034432 | 0.93 | MAPT (0.44) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL22034455 | 0.92 | MAPT (0.43) | MAPTCYP2D6THRBHSD17B10CA2 | |
| SCHEMBL22076451 | 0.91 | MAPT (0.47) | MAPTCYP2D6THRBHSD17B10CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465944-B1 | NOVEL CARBOHYDRATE ESTERS AND POLYOL ESTERS AS PLASTICIZERS FOR POLYMERS, COMPOSITIONS AND ARTICLES INCLUDING SUCH PLASTICIZERS AND METHODS OF USING THE SAME | EASTMAN CHEM CO (US) | 2015-02-25 | — | — | EP | claimed |
| CN-119452026-A | Cellulose ester polymer compositions having low coefficient of friction | 乐高公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-117700565-A | Recovery of component cellulose esters | 伊士曼化工公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-114072429-B | Recovery of component cellulose esters | 伊士曼化工公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117178017-A | Ophthalmic articles having high toughness and dimensional stability made from cellulose ester compositions | 伊士曼化工公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-110168005-B | Cellulose ester and impact modifier compositions and articles made using these compositions | 伊士曼化工公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-110168004-B | Polymer-based resin compositions derived from cellulose and articles made using these compositions | 伊士曼化工公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-111684004-B | Cellulose esters and polymeric aliphatic polyester compositions and articles | 伊士曼化工公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-110168006-B | Cellulose ester and ethylene-vinyl acetate compositions and articles made using these compositions | 伊士曼化工公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-110168007-B | Polymer-based resin compositions derived from cellulose and articles made using these compositions | 伊士曼化工公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-4118123-A1 | LOW HYDROXYL CONTENT CELLULOSE ESTER AND POLYMERIC ALIPHATIC POLYESTER COMPOSITIONS AND ARTICLES | Eastman Chemical Company (US) | 2023-01-18 | — | — | EP | disclosed |
| EP-4085096-A1 | MOLDED ARTICLES FOR USE WITH TERPENE CONTAINING OILS | Eastman Chemical Company (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-111684005-B | Cellulose esters and polymerized aliphatic polyester compositions and articles | 伊士曼化工公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-115244086-A | Low hydroxyl content cellulose esters and polymeric aliphatic polyester compositions and articles | 伊士曼化工公司 | 2022-10-25 | — | — | CN | disclosed |
| WO-2022216473-A1 | OPHTHALMIC ARTICLES MADE FROM CELLULOSE ESTER COMPOSITIONS HAVING HIGH TOUGHNESS AND DIMENSIONAL STABILITY | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | WO | disclosed |
| CN-114981350-A | Molded articles for use with terpene-containing oils | 伊士曼化工公司 | 2022-08-30 | — | — | CN | disclosed |
| EP-3976661-A1 | RECYCLE CONTENT CELLULOSE ESTER | Eastman Chemical Company (US) | 2022-04-06 | — | — | EP | disclosed |
| CN-114072429-A | Recovery of constituent cellulose ester | 伊士曼化工公司 | 2022-02-18 | — | — | CN | disclosed |
| US-10953027-B2 | Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-03-23 | — | — | US | disclosed |
| US-20200197428-A1 | ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE | FLAGSHIP PIONEERING, INC. | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200197428-A1 | ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE | FABP1, PYGL, LIPC | MAPT 3186/4885CYP2D6 1191/4885THRB 646/4885 |
| US-10953027-B2 | Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease | FABP1, PYGL, LIPC | MAPT 3186/4885CYP2D6 1191/4885THRB 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.